All In Biotech

Free tool

FAERS Monitor: Cholbam

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205750 or its brand name (Cholbam, Cholic Acid). Reports on generic versions are filed under their own applications.

Reports

403

Serious

190

47% of reports

Hospitalization

89

Death reported

72

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea58
  • death40
  • vomiting29
  • pyrexia21
  • seizure20
  • constipation19
  • aspartate aminotransferase increased18
  • alanine aminotransferase increased17
  • disease progression16
  • abdominal pain13
  • cough13
  • nasopharyngitis13
  • decreased appetite11
  • gastrooesophageal reflux disease10
  • liver function test increased10

Reports by year received

View as table
YearReports
20091
20153
201620
201718
201840
201943
202047
202139
202231
2023115
202428
20259
20269

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,756 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
liver function test increasedSignal1024.313.2201
aspartate aminotransferase increasedSignal1817.711.3268
alanine aminotransferase increasedSignal1714.59.1200
seizureSignal209.05.9136
disease progressionSignal167.14.478
gastrooesophageal reflux diseaseSignal106.53.541
diarrhoeaSignal584.73.7170
constipationSignal194.52.950
nasopharyngitisSignal133.72.223
vomitingSignal293.22.343
pyrexiaSignal213.22.130
abdominal painSignal132.91.715
decreased appetiteSignal112.51.48
deathSignal402.41.833
coughSignal132.41.410

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.